Navigation Links
Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development

SEATTLE, Aug. 19 /PRNewswire/ -- Sound Pharmaceuticals (SPI) has received a $2.1 million research and development award from the Office of Naval Research, Science and Technology Division. This new funding will expand the ongoing development of SPI-1005 in to other areas of sensorineural hearing loss. SPI-1005, an oral form of a glutathione peroxidase mimic, is currently being tested in a Ph-II clinical trial aimed to protect and treat blast exposed active duty personnel in the Dept. of Defense. This contract marks the third award from the ONR to SPI since 2005, bringing the total level of ONR funding to $5 million.

"This award will allow SPI to identify other protein or drug targets which will foster the development of otoprotection product pipeline," said Jonathan Kil, Principal Investigator. SPI has developed three proprietary product pipelines for several different types of hearing loss indications including noise induced, tinnitus, chemotherapy induced and age-related hearing loss. In addition, SPI intends to apply these drug candidates to other neurodegenerative diseases including traumatic brain injury.

According to two recent studies conducted by Clarity and The Ear Foundation, approximately 50% of the 76 million Baby Boomers in the U.S. are experiencing some degree of hearing loss. These findings suggest that hearing loss has become the leading chronic disease or disorder in adults aged 45-64. In addition, approximately 25% of the hearing impaired, felt that they had reduced success at work and in earning potential. Currently there are no FDA approved drugs for the prevention and treatment of hearing loss. SPI hopes to address this unmet medical need with its first in class first in indication drug.

Sound Pharmaceuticals, Inc. is a privately held biopharmaceutical company with a focus on developing the first drugs for hearing loss and brain injury. For more information please contact Jonathan Kil, MD, President and CEO, 206-634-2559 or

SOURCE Sound Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Human mind: Sound and vision wired through same black box
2. Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain
3. Tennis Elbow, Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound
4. Cochlear Americas Announces FDA Clearance of the Cochlear(TM) Baha(R) BP100 Sound Processor, the Industrys First Programmable Bone Conduction Hearing Solution
5. SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal
6. AIUM announces management agreement with the International Society of Therapeutic Ultrasound
7. Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound
8. Acoustiblok, Inc. Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution
9. Havels Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada
10. Perfect Fathers Day Gift: The Sound of Silence
11. Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: